Advanced search
Publication Cover
Future Medicinal Chemistry Volume 8, 2016 - Issue 12
Submit an article Journal homepage
796
Views
0
CrossRef citations to date
0
Altmetric
Special Focus: Antifungal drug discovery – Editorial

Challenges in the Development of Novel Anticryptococcal Agents

Damian J Krysana Departments of Microbiology/Immunology, University of Rochester School of Medicine & Dentistry, Rochester, NY14642, USA;b Pediatrics, University of Rochester School of Medicine & Dentistry, Rochester, NY14642, USACorrespondence[email protected]
View further author information
Pages 1375-1377 | Received 19 May 2016, Accepted 06 Jun 2016, Published online: 03 Aug 2016

References

  • Brown GD , DenningDW, GowNA, LevitzSM, NeteaMG, WhiteTC. Hidden killers: human fungal infections. Sci. Transl. Med.19 (4), 165 (2012).
  • Park BJ , WannemuehlerKA, MarstonBJ, GovenderN, PappasPG, ChillerTM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS23 (4), 525–530 (2009).
  • Sloan DJ , DedicoatMJ, LallooDG. Treatment of cryptococcal meningitis in resource-limited settings. Curr. Opin. Infect. Dis.22 (5), 455–463 (2009).
  • Boulware DR , MeyaDB, MuzooraCet al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N. Engl. J. Med.370 (26), 2487–2498 (2014).
  • Loyse A , ThangarajH, EasterbrookPet al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect. Dis.13 (7), 629–637 (2013).
  • Day JN , ChauTT, WolbersMet al. Combination antifungal therapy for cryptococcal meningitis. N. Engl. J. Med.368 (14), 1291–1302 (2013).
  • Loyse A , DromerF, DayJ, LortholaryO, HarrisonTS. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. J. Antimicrob. Chemother.68 (11), 2435–2444 (2013).
  • Jarvis JN , BicanicT, LoyseAet al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin. Infect. Dis.58 (5), 736–745 (2014).
  • Thompson GR 3rd , RendonA, Dos SantosRRet al. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin. Infect. Dis. pii: ciw305 (2016) ( Epub ahead of print).
  • Butts A , DiDoneL, KoselnyKet al. A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis. Eukaryot. Cell12 (2), 278–287 (2013).
  • Brown JC , NelsonJ, VanderSluisBet al. Unraveling the biology of a fungal meningitis pathogen using chemical genetics. Cell159 (5), 1168–1187 (2014).
  • Maligie MA , SelitrennikoffCP. Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins. Antimicrob. Agents Chemother.49 (7), 2851–2856 (2005).
  • Rabjohns JL , ParkYD, DehdashtiJet al. A high-throughput screening assay for fungicidal compounds against Cryptococcus neoformans. J. Biomol. Screen.19 (2), 270–277 (2014).
  • Hartland K , PuJ, PalmerMet al. High-throughput screen in Cryptococcus neoformans identifies a novel molecular scaffold that inhibits cell wall integrity pathway signaling. ACS Infect. Dis.2 (1), 93–102 (2016).
  • Frail DE , BradyM, EscottKJet al. Pioneering government-sponsored drug repositioning collaborations: progress and learning. Nat. Rev. Drug Discov.14 (12), 833–841 (2015).
  • Zhai B , WuC, WangL, SachsMS, LinX. The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections. Antimicrob. Agents Chemother.56 (7), 3758–3766 (2012).
  • Rhein J , MorawskiBM, HullsiekKHet al. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study. Lancet Infect. Dis.16 (7), 809–818 (2016)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.